Evidence mapPaperPMID 35434900Full record

ReviewJournal of diabetes2022

Current gaps in management and timely referral of cardiorenal complications among people with type 2 diabetes mellitus in the Middle East and African countries: Expert recommendations.

Alper Sonmez, Hani Sabbour, Akram Echtay, Abbas Mahdi Rahmah, Amani Matook Alhozali, Fahad Sulman Al Sabaan, Fares H Haddad, Hinde Iraqi, Ibrahim Elebrashy, Samir N Assaad and 3 more

Open access · goldAbstract readReview
In one paragraph

Review in Journal of diabetes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Critical questions in diabetes management: What are the most compelling challenges and how can we handle them?International journal of cardiology. Cardiovascular risk and prevention · 2022
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 13 institutions in 13 countries.

Alper SonmezDepartment of Endocrinology and Metabolism, Gulhane School of Medicine, University of Health Sciences, Ankara, Turkey.ORCID https://orcid.org/0000-0002-9309-7715
Hani SabbourHeart & Vascular Institute Cleveland Clinic, Abu Dhabi, UAE.ORCID https://orcid.org/0000-0001-6960-1056
Akram EchtaySchool of Medicine, Lebanese University, Hadath, Lebanon.
Abbas Mahdi RahmahNational Centre for Diabetes, College of Medicine, Al-Mustansriya University, Baghdad, Iraq.
Amani Matook AlhozaliDepartment of Medicine, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
Fahad Sulman Al SabaanSecurity Forces Hospital, Riyadh, Saudi Arabia.
Fares H HaddadEndocrine & Diabetes, Abdali Hospital/Endocrine & Diabetes Clinic, Amman, Jordan.
Hinde IraqiFaculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
Ibrahim ElebrashyFaculty of Medicine, Cairo University, Cairo, Egypt.
Samir N AssaadUniversity of Alexandria, Alexandria, Egypt.
Zaheer BayatDivision of Endocrinology and Metabolism, Department of Internal Medicine, Helen Joseph Hospital, Rossmore, Johannesburg, South Africa.
Zeynep Osar SivaTurkish Diabetes Association, Turkey.
Mohamed HassaneinDubai Hospital, DHA, Dubai, UAE.
Alexandria University · EGCairo University · EGCleveland Clinic · USDanish Diabetes Association · DKGulf Medical University · AEGülhane Askerî Tıp Akademisi · TRHelen Joseph Hospital · ZAJordan Hospital · JOKing Abdulaziz University · SALebanese University · LBMohammed V University · MAMustansiriyah University · IQSecurity Forces Hospital · SA

Funding

AstraZeneca Good Publication Practice (GPP) 3AstraZeneca, Middle East Africa
6 · The paper itself

Abstract

The upsurge of type 2 diabetes mellitus is a major public health concern in the Middle East and North Africa (MENA) and Africa (AFR) region, with cardiorenal complications (CRCs) being the predominant cause of premature morbidity and mortality. High prevalence of cardiometabolic risk factors, lack of awareness among patients and physicians, deficient infrastructure, and economic constraints lead to a cascade of CRCs at a significantly earlier age in MENA and AFR. In this review, we present consensus recommendations by experts in MENA and AFR, highlighting region-specific challenges and potential solutions for management of CRCs. Health professionals who understand sociocultural barriers can significantly increase patient awareness and encourage health-seeking behavior through simple educational tools. Increasing physician knowledge on early identification of CRCs and personalized treatment based on risk stratification, alongside optimum glycemic control, can mitigate therapeutic inertia. Early diagnosis of high-risk people with regular and systematic monitoring of cardiorenal parameters, development of region-specific care pathways for timely referral to specialists, followed by guideline-recommended care with novel antidiabetics are imperative. Adherence to guideline-recommended care can catalyze utilization of sodium glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists with demonstrated cardiorenal benefits-thus paving the way for overcoming care gaps in a cost-effective manner. Leveraging digital technology like electronic medical records can help generate real-world data and provide insights on voids in adoption of newer antidiabetic medications. A patient-centric approach, collaborative care among physicians from different specialties, alongside involvement of policy makers are key for improving patient outcomes and quality of care in MENA and AFR.

Indexed as

Diabetes Mellitus, Type 2Sodium-Glucose Transporter 2 InhibitorsAfrica, NorthernHumansHypoglycemic AgentsMiddle EastReferral and ConsultationHypoglycemic AgentsSodium-Glucose Transporter 2 Inhibitors2型糖尿病cardiovascular risk managementdiabetic cardiomyopathydiabetic kidney diseaseMiddle East and North Africa and Africatype 2 diabetes mellitus中东和非洲心血管风险管理糖尿病心肌病糖尿病肾病

Identifiers

PMID35434900
PMCPMC9366572
OpenAlexW4223918550

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.